Evidence map›Paper›PMID 34961553›Full record

ArticleJournal of medical case reports2021

Gestational breast cancer in a patient with Crohn's disease: two case reports.

Mohammed Al-Arsan Al-Yaseen, Salah Aldin Haydar, Mousa Alali, Maher Saifo

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of medical case reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Mohammed Al-Arsan Al-YaseenFaculty of Medicine, Damascus University, Fayez Mansour Street, P. O. Box: 222, Damascus, Syria.
Salah Aldin HaydarFaculty of Medicine, Damascus University, Fayez Mansour Street, P. O. Box: 222, Damascus, Syria.
Mousa AlaliDepartment of Oncology, Al-Bairouni University Hospital, Damascus University, Harasta M5, Damascus, Syria.
Maher SaifoFaculty of Medicine, Damascus University, Fayez Mansour Street, P. O. Box: 222, Damascus, Syria. maher.saifo@aspu.edu.sy.ORCID http://orcid.org/0000-0002-5418-3186
Damascus University · SYDamascus Hospital · SY

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDiagnosis of breast cancer during gestation is a rare occurrence. In addition, the diagnosis of breast cancer in a patient with Crohn's disease is not common. We present a rare case of gestational breast cancer in a patient with Crohn's disease, with a concurrent breast cancer diagnosis in her sister. CASE PRESENTATION: A 31-year-old Syrian woman with Crohn's disease was diagnosed with breast cancer at 30 weeks gestation; she received neoadjuvant chemotherapy during gestation. Incidentally, her 37-year-old sister was also diagnosed concomitantly with breast cancer. Both sisters underwent and successfully completed surgery and adjuvant therapy. At a 5-year review, both patients showed no signs of recurrence. The Crohn's disease symptoms have also improved after chemotherapy, and the baby born after gestational chemotherapy is currently 5 years old with normal psychomotor development and without any congenital malformations.

conclusionsThis case report highlights the impact of gestation on breast cancer outcomes, the possibility of giving chemotherapy during gestation, and the effect of chemotherapy on the symptoms of Crohn's disease.

Indexed as

Breast NeoplasmsCrohn DiseaseAdultChild, PreschoolFemaleHumansNeoadjuvant TherapyChemotherapyCrohn’s diseaseFamilial breast cancerGestationLobular carcinoma

Identifiers

PMID34961553
PMCPMC8711207
OpenAlexW4200124775

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.